메뉴 건너뛰기




Volumn 5, Issue 5, 2017, Pages 327-328

Theory and Fact: Revisiting Association and Causation

Author keywords

biomarkers; endothelin; endothelin antagonists; prognosis

Indexed keywords

BIOLOGICAL MARKER; BOSENTAN; ENDOTHELIN 1; PLACEBO; ANTIHYPERTENSIVE AGENT; ENDOTHELIN RECEPTOR ANTAGONIST;

EID: 85018678907     PISSN: 22131779     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchf.2017.03.005     Document Type: Editorial
Times cited : (2)

References (6)
  • 1
    • 0141928042 scopus 로고
    • The Story of the Malakand Field Force
    • Dover London, UK
    • 1 Churchill, W., The Story of the Malakand Field Force. 1898, Dover, London, UK.
    • (1898)
    • Churchill, W.1
  • 2
    • 0039758163 scopus 로고    scopus 로고
    • The Vision of the Anointed: Self-Congratulation as a Basis for Social Policy
    • Basic Books New York, NY
    • 2 Sowell, T., The Vision of the Anointed: Self-Congratulation as a Basis for Social Policy. 1996, Basic Books, New York, NY.
    • (1996)
    • Sowell, T.1
  • 3
    • 10344260652 scopus 로고    scopus 로고
    • Superiority of big endothelin-1 and endothelin-1 over natriuretic peptides in predicting survival in severe congestive heart failure: a 7-year follow-up study
    • 3 Van Beneden, R., Gurné, O., Selvais, P.L., et al. Superiority of big endothelin-1 and endothelin-1 over natriuretic peptides in predicting survival in severe congestive heart failure: a 7-year follow-up study. J Card Fail 10 (2004), 490–495.
    • (2004) J Card Fail , vol.10 , pp. 490-495
    • Van Beneden, R.1    Gurné, O.2    Selvais, P.L.3
  • 4
    • 33744779924 scopus 로고    scopus 로고
    • The prognostic value of big endothelin-1 in more than 2,300 patients with heart failure enrolled in Valsartan Heart Failure Trial (Val-HeFT)
    • 4 Masson, S., Latini, R., Anand, I.S., et al. The prognostic value of big endothelin-1 in more than 2,300 patients with heart failure enrolled in Valsartan Heart Failure Trial (Val-HeFT). J Card Fail 12 (2006), 375–380.
    • (2006) J Card Fail , vol.12 , pp. 375-380
    • Masson, S.1    Latini, R.2    Anand, I.S.3
  • 5
    • 84924580810 scopus 로고    scopus 로고
    • Prognostic significance of active and modified forms of endothelin 1 in patients with heart failure with reduced ejection fraction
    • 5 Gottlieb, S.S., Harris, K., Todd, J., et al. Prognostic significance of active and modified forms of endothelin 1 in patients with heart failure with reduced ejection fraction. Clin Biochem 48 (2014), 292–296.
    • (2014) Clin Biochem , vol.48 , pp. 292-296
    • Gottlieb, S.S.1    Harris, K.2    Todd, J.3
  • 6
    • 85018713668 scopus 로고    scopus 로고
    • Long-term effect of endothelin receptor antagonism with bosentan on the morbidity and mortality of patients with severe chronic heart failure: primary results of the ENABLE trials
    • 6 Packer, M., McMurray, J.J.V., Krum, H., et al. Long-term effect of endothelin receptor antagonism with bosentan on the morbidity and mortality of patients with severe chronic heart failure: primary results of the ENABLE trials. J Am Coll Cardiol HF 5 (2017), 317–326.
    • (2017) J Am Coll Cardiol HF , vol.5 , pp. 317-326
    • Packer, M.1    McMurray, J.J.V.2    Krum, H.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.